BRWA
TGTX icon

B. Riley Wealth Advisors’s TG Therapeutics TGTX Stock Holding History

B. Riley Wealth Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7,085
Closed -$342K – 1465
2021
Q1 		$342K Sell
7,085
-722
-9% -$34.7K 0.01% 931
2020
Q4 		$407K Sell
7,807
-6,463
-45% -$218K 0.02% 603
2020
Q3 		$382K Buy
14,270
+1,950
+16% +$44.9K 0.02% 635
2020
Q2 		$240K Sell
12,320
-700
-5% -$11.3K 0.02% 703
2020
Q1 		$129K Buy
13,020
+2,620
+25% +$33.1K 0.01% 713
2019
Q4 		$115K Buy
10,400
+100
+1% +$760 0.01% 792
2019
Q3 		$58K Sell
10,300
-100
-1% -$697 0.01% 785
2019
Q2 		$90K Sell
10,400
-3,500
-25% -$26.5K 0.01% 759
2019
Q1 		$111K Hold
13,900
– – 0.01% 696
2018
Q4 		$58K Buy
+13,900
New +$69.1K 0.01% 640
2015
Q1 		– Sell
-7,823
Closed -$124 – 1846
2014
Q4 		$124 Buy
+7,823
New +$102K ﹤0.01% 1604
2014
Q3 		– Sell
-8,823
Closed -$82.8K – 1761
2014
Q2 		$82.8K Sell
8,823
-4,524
-34% -$28.9K 0.02% 804
2014
Q1 		$92K Buy
+13,347
New +$79K 0.03% 636
2013
Q4 		– Sell
-11,194
Closed -$56K – 717
2013
Q3 		$56K Hold
11,194
– – 0.02% 631
2013
Q2 		$72K Buy
+11,194
New +$71.7K 0.02% 623

Other funds holding TGTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

B. Riley Wealth Advisors's TGTX Position: Q2 2021 in Review

B. Riley Wealth Advisors sold out of TG Therapeutics (TGTX) in Q2 2021, closing a stake of 7,085 shares — an estimated $342K sold.

B. Riley Wealth Advisors first reported a position in TGTX in Q2 2013 and held it in 15 quarters. The position peaked at $407K in Q4 2020. 237 funds tracked by Wall St. Rank hold TGTX as of Q2 2021.

  • B. Riley Wealth Advisors reported no remaining TG Therapeutics position as of Q2 2021 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 7,085 TG Therapeutics shares in Q2 2021, an estimated $342K.
  • B. Riley Wealth Advisors first reported a position in TG Therapeutics in Q2 2013 and held it in 15 quarters.
  • B. Riley Wealth Advisors's TG Therapeutics position peaked at $407K in Q4 2020.
  • 237 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2021.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.